Özet:

Aim: In our study, which included both pediatric and adult patients; we aimed to contribute to the follow-up of patients by evaluating the two-year demographic and clinical data of Herpes Zoster patients who were followed and treated in the dermatovenerology clinic of a secondary level hospital. Material and Methods: In this cross-sectional study, the clinic and epidemiological records of patients who were clinically diagnosed with herpes zoster in the Denizli State Hospital Dermatovenerology outpatient clinic between October 2020 and October 2022 were evaluated retrospectively. Results: The age range was between 2 and 94 among 289 HZ patients, and the mean age was 52.12 ±22.635 years. Fifty-three percent were female and 47 % were male. While the 18-65 age group was the most crowded group with 166 (57.43%) patients, there were 33 (11.41%) patients under the age of 18. A history of predisposing factors was found in 85.1% of the patients. Stress was detected the most common predisposing factor in adults and infections in childhood. A history of an additional systemic comorbidity was found in %69.2 of the patients, and additional dermatologic comorbidity was found in %68.1 of the patients. Complications were found in 60.2% of the patients, and 52.6% had postherpetic neuralgia. It was observed that 9% of the patients were hospitalized. Conclusion: In our study, we determined the clinical and epidemiological data of HZ patients we followed in Denizli during the years under the influence of the COVID-19 pandemic, and the risk factors associated with HZ complications. We consider that morbidity and mortality caused by complications can be significantly reduced by informing the society about disease, vaccinating risk groups, early appointment to hospital, appropriate treatment, close follow-up and hospitalization when necessary.